The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1423-0410|108|3|262-267

ISSN： 0042-9007

Source： VOX SANGUINIS, Vol.108, Iss.3, 2015-04, pp. : 262-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5‐year experience

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 746-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 6, 2015-09 ,pp. : 745-756

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delayed hemolytic transfusion reaction in adult sickle‐cell disease: presentations, outcomes, and treatments of 99 referral center episodes

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : 989-994

John Wiley & Sons Inc

Access to resources Recommend Favorite

Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 2, 2015-01 ,pp. : 291-300

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 425-428

John Wiley & Sons Inc

Access to resources Recommend Favorite